University Hospital (UZ) Leuven

Leuven 3000

1 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumors, Cholangiocarcinoma, Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Epitheliod Sarcoma (ES), Esophageal Cancer, Follicular Lymphoma (FL), HER2 Exon 20 Mutation, Hepatocellular Carcinoma (HCC), Mesothelioma, Metastatic Adenocarcinoma of the Pancreas

Studies at this site

• Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL — Recruiting now
• A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment — Completed
• Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy — Completed
• A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study — Completed
• An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies — Stopped early
• Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). — Stopped early
• Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) — Stopped early